Sal Bisulca

Owner at DECA - Florence, Kentucky, United States

Sal Bisulca's Contact Details
HQ
+1 859-384-3600
Location
Huntington Station,New York,United States
Company
DECA
Sal Bisulca's Company Details
DECA logo, DECA contact details

DECA

Florence, Kentucky, United States • 13 Employees
Pharmaceuticals

DECA is a privately held product development organization dedicated to the creation of innovative healthcare technologies designed for seamless integration into our global sales network.Our technologies are formulated by board certified pharmacologists and undergo rigorous safety, tolerability and efficacy testing and are then proven IRB reviewed human clinical trials. Once safety and efficacy are confirmed the technology is professionally positioned to maximize valuation by strategic introduction into our global commercialization network. DECA has developed numerous platform technologies that have become cornerstone products for some highly successful companies including Richwood Pharmaceuticals (Merged with Shire Pharmaceuticals in 1997), Integrity Pharmaceuticals, Xanodyne Pharmaceuticals and the Union Springs Family of Companies (Acquired by Enzymotec LTD NASDAQ ENZY 2017).

Details about DECA
Frequently Asked Questions about Sal Bisulca
Sal Bisulca currently works for DECA.
Sal Bisulca's role at DECA is Owner.
Sal Bisulca's email address is ***@decausa.com. To view Sal Bisulca's full email address, please signup to ConnectPlex.
Sal Bisulca works in the Pharmaceuticals industry.
Sal Bisulca's colleagues at DECA are Tom Lievens, Lisa Speed, Kaci Pike, Nicholas Breig, Valentina Cangini, Becky Walker and others.
Sal Bisulca's phone number is +1 859-384-3600
See more information about Sal Bisulca